THE 2026
EUROPEAN ALDOSTERONE CONFERENCE MEETING
The 2026 European Aldosterone Conference meeting, co organized with INI-CRCT, will be held on October 16-17, 2026 in Kremlin-Bicêtre, near Paris, France, to provide the opportunity to meet and network with colleagues from Europe. The main topic of the meeting is to discuss novel indications and pharmacological approaches (e.g. recently approved non-steroidal MRA, aldosterone synthase inhibitors, incretins, SGLT2 inhibitors) for therapeutic targeting of the mineralocorticoid pathway or different sites of the RAAS. The meeting covers the full spectrum from basic science to clinical application.
The 2026 European Aldosterone Conference meeting, co organized with INI-CRCT, will be held on October 16-17, 2026 in Kremlin-Bicêtre, near Paris, France, to provide the opportunity to meet and network with colleagues from Europe. The main topic of the meeting is to discuss novel indications and pharmacological approaches (e.g. recently approved non-steroidal MRA, aldosterone synthase inhibitors, incretins, SGLT2 inhibitors) for therapeutic targeting of the mineralocorticoid pathway or different sites of the RAAS. The meeting covers the full spectrum from basic science to clinical application.
It’s them. ESAC 2026.
The ESAC Congress brings together more than 100 experts from 10 European countries, representing a diverse network of clinicians, researchers and scientists committed to advancing research and clinical practice in the field of aldosterone and the renin-angiotensin-aldosterone system (RAAS)
F. JAISSER
France
MC. ZENNARO
France
S. VIENGCHAREUN
France
S. BOULKROUN
France
M. ZHAO
France
F. FERNANDES-ROSA
France
B. FÈVE
France
A. OUVRARD-PASCAUD
France
MEETING PROGRAM
Admire
paris
again
research
building
Research Building Paris-Saclay
Medical School 63 rue Gabriel Péri
94276 Le Kremlin-Bicêtre Cedex | France
With line 14: The Research building is in front of you (3 min on foot) Take line 14, direction « Orly – Aéroport » Get off at the station « Hôpital Bicêtre »
REGISTRATION &
ABSTRACT SUBMISSION :
• All abstracts must be submitted in English. Abstracts submitted in other languages will be automatically rejected!
• Please note that the abstract word limit is 400 words, excluding the list of authors and affiliations.
• The name of the presenting author should be underlined
• The abstract must be formatted in Arial 11-pt, and submitted as a one-page PDF file
• The submission deadline is July 5 , 2026
• The designated presenting author must register to attend the ESAC 2026 congress and present the work during the congress
• You will be notified of accptance by mid-July 2026
• During the submission process, you will be asked to indicate your prefered presentation type : oral or poster.
Please note that this is to indicate preference only. The ESAC 2026 Programme Organising Committee will have the final decision on the presentation types of all abstracts.
• You will also be asked to indicate whether you would like to be considered for participation in the Brian Harvey Young Investigator Award. To be considered, author must be a PhD applicant or less than 5-years of PhD
We hope
to see you !